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Impact of the Gly573Ser Substitution in TRPV3 on
the Development of Allergic and Pruritic Dermatitis
in Mice
Takeshi Yoshioka1, Kinichi Imura1, Makoto Asakawa1, Minoru Suzuki1, Itsuki Oshima1, Tsutomu Hirasawa1,
Tsuneaki Sakata1, Tatsuya Horikawa2 and Akinori Arimura1
We reported that the Gly573Ser substitution in transient receptor potential vanilloid 3 (TRPV3) led to increased
ion channel activity in keratinocytes and caused spontaneous hairlessness in DS-Nh mice. DS-Nh mice also
develop allergic and pruritic dermatitis. As the hairless and dermatitis phenotypes were both inherited in an
autosomal dominant fashion and could not be segregated from each other, we speculated that TRPV3Gly573Ser
might be responsible for the dermatitis. Here, we constructed TRPV3Gly573Ser transgenic mice, with a putative
promoter sequence in the 50 region of TRPV3, to investigate the involvement of TRPV3 in the development of
specific types of dermatitis. These transgenic mice spontaneously developed dermatitis, whereas wild-type
mice did not display this phenotype when maintained under the same conditions. Histological and serological
analyses were carried out to better understand the clinical features of TRPV3Gly573Ser transgenic mice.
A physiological study revealed that TRPV3Gly573Ser induced a higher nerve growth factor response to heat.
Finally, C57BL-Nh mice were used to investigate the penetrance of the TRPV3Gly573Ser gene for dermatitis.
Interestingly, C57BL-Nh mice developed spontaneous scratching behavior, separately from the development of
dermatitis. We propose that TRPV3Gly573Ser is a cause of pruritus and/or dermatitis associated with scratching,
and suggest that TRPV3 may represent a therapeutic target in pruritic dermatitis.
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INTRODUCTION
Transient receptor potential (TRP) channels, which are
important in maintaining vital activities, are expressed in
almost all organs in the body (Okuhara et al., 2007).
Moreover, there are suggestions that some TRP channels
are involved in several diseases (Nilius et al., 2007). They are
key players in sensory systems, responding to temperature,
touch, pain, osmolarity, pheromones, taste, and other stimuli
(Clapham, 2003). TRP vanilloid subfamily (TRPV) channels
are members of the TRP family, and some of these are
expressed in skin (Vennekens et al., 2008). Some investiga-
tors have speculated that certain members of the TRPV
subfamily, which are highly expressed in epidermal keratino-
cytes and act as cellular temperature sensors, are important
role as sensors for pruritus. (Paus et al., 2006; Steinhoff et al.,
2006). They also noted the possibilities of these channels as
therapeutic targets in pruritus.
Although functional TRPV3, which is expressed at high
levels in skin keratinocytes (Peier et al., 2002; Moqrich et al.,
2005), is activated by physiologic temperature (Xu et al.,
2002), inflammatory mediators, (Hu et al., 2006) and nitric
oxide (Yoshida et al., 2006), the biologic role of TRPV3 is not
fully understood. We recently reported that the Gly573Ser
substitution in TRPV3 caused a hairless phenotype in DS-Nh
mice and WBN/Kob-Ht rats (Asakawa et al., 2005, 2006;
Imura et al., 2007). Furthermore, this Gly573Ser substitution
renders the TRPV3 channel spontaneously active under
normal physiological conditions (Xiao et al., 2008b). DS-Nh
mice also developed atopic dermatitis (AD; Hikita et al.,
2002; Yoshioka et al., 2003, 2006, 2007). Interestingly,
Gopinath et al. (2005) speculated that increased expression
of TRPV3 may affect the production of nerve growth factor
(NGF) by keratinocytes. This NGF, which was derived from
keratinocytes and was recognized to be a major pruritogen
(Paus et al., 2006; Steinhoff et al., 2006), was important in the
development of AD or AD-like dermatitis via its stimulation
of pruritus and subsequent scratching behavior (Kanda and
Watanabe 2003; Yoshioka et al., 2006). As these hairless and
dermatitis phenotypes were both inherited in an autosomal
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dominant fashion and could not be segregated from each
other by breeding procedures in DS-Nh mice (Asakawa et al.,
2006), we hypothesized that TRPV3Gly573Ser may also cause
pruritic dermatitis. Here, we developed TRPV3Gly573Ser
transgenic mice with a putative promoter sequence in the
50 region of TRPV3, and report that these mice developed
allergic and pruritic dermatitis.
Next, C57BL/6-Nh mice were bred and used to investigate
the penetrance of the TRPV3Gly573Ser gene for dermatitis,
because C57BL/6 mice show a Th1 response to the
intracellular pathogen, Leishmania major, and are highly
resistant to allergen stimulation. Curiously, spontaneous
scratching behavior and characteristic pathologic findings,
which were thought to be caused by TRPV3Gly573Ser, were
observed in C57BL/6-Nh mice even though they did not
develop dermatitis. Based on these results, we conclude that
TRPV3 may represent a potential therapeutic target in allergic
and/or pruritic dermatitis.
RESULTS
Production of transgenic mice
We previously reported that the Gly573Ser substitution in
TRPV3 caused hairlessness in rodents, suggesting that either
the genes responsible for allergic and pruritic dermatitis are
located adjacent to TRPV3, or that TRPV3 itself may be a
cause of such dermatitis (Asakawa et al., 2005, 2006). Here,
we produced TRPV3Gly573Ser transgenic mice in order to
investigate the involvement of TRPV3 in the development of
this form of dermatitis. To evaluate the role of TRPV3 using
transgenic mice, it is necessary to control both the quality and
quantity of its expression and we therefore constructed
vectors containing a series of lengths of the 50 region of
TRPV3, to determine its native promoter sequence. The
lengths of these putative promoter sequences were 2,054,
941, 750, and 436 nucleotides, from their beginnings at the
initiation codon (Figure 1a). All of these fragments have
sufficient promoter activity compared to the viral promoter
(Figure 1b) and the shortest one was used to construct several
lines of transgenic mice (designated Tg-1, -2, -3, -4, -5, and -
6). To exclude lines of transgenic mice with no gene transfer,
we carried out Southern blot analyses to detect endogenous
and introduced TRPV3. Bands representing the endogenous
gene and the transgene were detected in all the transgenic
lines, but two distinct types of lines could be differentiated
based on the level of transgene expression: one type
possessed 1–2 copies of the introduced gene (Tg-2), whereas
the other possessed 410 copies of the introduced gene (Tg-4;
Figure 1c).
TRPV3 expression and clinical features in TRPV3Gly573Ser
transgenic mice
Transgenic TRPV3Gly573Ser was only recognized in the Tg-2
line (data not shown), and immunohistochemical analysis
and reverse transcription–PCR were therefore performed to
confirm the expression of the transgene in this line. The Tg-2
line of transgenic mice was used in subsequent experiments.
As shown in Figure 2a, TRPV3 protein was detected in
epidermal keratinocytes using two kinds of anti-TRPV3
antibodies. As the transgenic mice were constructed using a
putative promoter sequence, the gene expression profile was
studied to determine the validity of the promoter sequence.
Real-time PCR data revealed high levels of TRPV3 expression
in the ears (skin) and testes in TRPV3Gly573Ser mice (Figure
2b), consistent with a previous report (Xu et al., 2002).
Restriction fragments of 150 bases derived from wild-type
TRPV3 and those of 131 bases derived from mutant TRPV3
were detected in Tg-2 mice (Figure 2c). As the size-related
intensity of the DNA fragments correlates with their amounts,
we used densitometric methods to estimate the amounts of
DNA based on the intensity of these bands and information
on their sizes. We found that about 50% of the expressed
TRPV3 in Tg-2 mice was derived from the transgene. The
clinical features of the transgenic mice with dermatitis at 30
weeks of age are shown in Figure 2d. Briefly, transgenic mice
raised under Staphylococcus aureus-free conditions for 20–25
weeks developed dermatitis, including erythema, edema, dry
skin, skin erosions, and excoriations.
Serological analyses of TRPV3Gly573Ser transgenic and DS mice
We measured the serum levels of total IgE, chemokine ligand
(CCL)11, CCL17, IL-13, IL-17, IFN-g, and monocyte chemo-
attractant protein-1 (MCP-1) in pooled serum samples from
30-week-old TRPV3Gly573Ser transgenic and DS mice main-
tained under specific pathogen-free (SPF) conditions, in order
to identify the fundamental and critical properties of the
dermatitis found in the transgenic mice. Based on studies
using two kinds of mice with the TRPV3Gly573Ser mutation,
Watanabe previously proposed that IgE hyperproduction was
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Figure 1. Putative promoter sequence in the 50 region of TRPV3 and
Southern blot analysis of endogenous and exogenous TRPV3 in transgenic
mice. (a) Schematic diagrams of the constructs of the putative promoter
sequence with the luciferase gene. (b) The promoter sequence was
determined by luciferase assays using XB-2 cells and a variety of sizes of the
putative promoter sequence. (c) Southern blot analysis was carried out to
detect endogenous and exogenous TRPV3 in transgenic mice. The upper
bands were derived from endogenous TRPV3 and their densities represent two
copies of TRPV3. The numbers of transgene copies were determined from the
blot by a densitometric method (Quantity One; Bio-Rad Laboratories Inc.),
based on the amounts of endogenous TRPV3 (two copies of TRPV3). The
numbers of transgene copies in transgenic lines Tg-2 and Tg-4 were 1–2 and
410 copies, respectively.
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regulated by the TRPV3Gly573Ser gene (Watanabe et al., 2003).
In this study, we also found that serum levels of total IgE were
significantly higher in Tg-2 mice at 30 weeks of age than in
age-matched DS mice (Figure 3). These results indicate that
TRPV3Gly573Ser transgenic mice act in a similar manner to DS-
Nh mice, produced by breeding procedures. Serum levels of
CCL11, CCL17, IL-13, IL-17, and MCP-1 were also signifi-
cantly higher in the transgenic mice at 30 weeks of age than
in age-matched DS mice (Figure 3).
Histochemical and immunohistochemical features
As mast cells and CD4-bearing T cells are important in the
development of human AD and AD-like dermatitis in DS-Nh
mice (Hikita et al., 2002; Yoshioka et al., 2003), we carried
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Figure 2. Evaluation of transgenic mice. (a) Skin samples collected from transgenic mice at 30 weeks of age were sectioned and stained with anti-TRPV3
polyclonal antibodies (VRL3-1 and VRL3-2). Red arrows indicate the basal layer of the epidermis. Bar¼ 100mm. (b) Expression levels of TRPV3 in a panel of
peripheral tissues, based on data obtained by TaqMan real-time quantitative RT-PCR. GAPDH (glyceraldehyde-3-phosphate dehydrogenase) RNA was used as
an internal reference for gene expression. The relative expression of TRPV3 was calculated using the following formula: relative expression of TRPV3 (%)¼ level
of expression of TRPV3 in each tissue/level of expression of TRPV3 in skin  100. (c) RNA was extracted from skin samples and used as a template for RT–PCR
to check the expression levels of the mutated TRPV3 transcripts in transgenic lines Tg-2 and Tg-4. We estimated the expression ratio of the mutated TRPV3
gene in these mice using a PCR-restriction fragment length polymorphism method (Asakawa et al., 2006). Briefly, we amplified the TRPV3 gene segment
overlapping a mutation site using a set of outside primers without bias. Next, PCR was carried out to introduce the Alu I site into the gene fragments with the
mutation, using a set of inner primers. After Alu I digestion, the PCR products were visualized by agarose gel electrophoresis and their size was estimated.
In mice with the mutated TRPV3, 150, 131, and 52 bp fragments were detected. 150 and 52 bp fragments were detected in mice without the mutated TRPV3.
(d) Transgenic mice maintained under SPF conditions for 30 weeks develop dermatitis. Bar¼ 100mm.
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Figure 3. Serological analyses of transgenic and DS mice. Pooled sera collected from 30-week-old mice maintained under SPF conditions were analyzed
for CCL11, CCL17, IL-13, IL-17, IFN-g, and MCP-1. Each value represents the mean±SD of 3–4 experiments. Statistical significance was determined by
Student’s t-test for unpaired two-group comparisons. NS, not significant.
716 Journal of Investigative Dermatology (2009), Volume 129
T Yoshioka et al.
TRPV3 and AD-Like Dermatitis
out histological analyses to elucidate the roles of these
inflammatory cells in the development of dermatitis in
TRPV3Gly573Ser transgenic mice. Significant histological
changes, such as pachyderma, hyperkeratosis, and infiltration
of high numbers of mast cells were observed in skin lesions
from all transgenic mice raised under SPF conditions,
compared with the situation in DS mice (Figure 4). Further-
more, infiltration of large numbers of CD4-bearing T cells
was observed in the transgenic mice (Figure 4), but not in DS
mice. These features show similarities with the symptoms of
human AD, and have also been reported to occur in DS-Nh
mice (Hikita et al., 2002).
Nerve density and NGF responses to heat
Recently, Gopinath speculated that TRPV3 might affect the
production of NGF by keratinocytes (Gopinath et al., 2005).
NGF from keratinocytes is known to be important in the
development of AD in humans (Toyoda et al., 2002) and AD-
like dermatitis in DS-Nh mice (Yoshioka et al., 2006), via
inflammatory exacerbation and pruritus. The levels of NGF
production in epidermal sheets from TRPV3Gly573Ser trans-
genic and DS mice incubated at 33 and 37 1C were examined
to clarify the possible relationship between TRPV3 and NGF
production. As shown in Figure 5a, the NGF responses at the
lower temperature (33 1C) were variable, but were higher in
sheets from transgenic mice than in those from DS mice. The
NGF responses at the higher temperature (37 1C) were similar
in the two types of mice. These results suggest that
TRPV3Gly573Ser in skin is activated at normal skin tempera-
ture, which would not be sufficient to activate endogenous,
wild-type TRPV3. This NGF response may be responsible for
the development of allergic and pruritic dermatitis in mice
with the Gly573Ser mutation. Next, we measured the tissue
levels of NGF in back skin samples from TRPV3Gly573Ser
transgenic and DS mice, to investigate the impact of the
transgene on increased NGF concentrations in vivo. The
levels of tissue NGF were significantly higher in the
transgenic mice at 30 weeks of age than in age-matched
DS mice (Figure 5b). As the levels of tissue NGF significantly
increased in the transgenic mice and NGF has potent
neuroprotective activity, we stained nerve fibers in skin
lesions from these mice at 30 weeks of age using antiprotein
gene product 9.5 (PGP9.5) antibody. Many PGP9.5-positive
cells were found in the transgenic mice raised under
conventional conditions with AD-like dermatitis (Figure 5c).
However, it is difficult to detect PGP9.5-positive cells in DS
mice without AD-like dermatitis (Figure 5c). This increase in
tissue NGF was thought to be essential for maintaining a
greater density of nerves at the epidermis in TRPV3Gly573Ser
transgenic mice, compared with DS mice (Figure 5c). We
then evaluated the scratching in 30-week-old TRPV3Gly573Ser
transgenic and DS mice to investigate the relationship
between TRPV3 and pruritus. Scratching behavior in the
transgenic mice was significantly increased compared with
that in DS mice (Figure 5d). We conclude that TRPV3 gain-of-
function is associated with NGF production by keratinocytes,
and that this association leads to increased levels of
epidermal NGF and increased nerve density, which in turn
cause AD-like dermatitis and pruritus, at least in rodents.
The penetrance of the TRPV3Gly573Ser gene for dermatitis
It is clear that TRPV3Gly573Ser causes hairlessness in many
kinds of mice (Asakawa et al., 2006), however, the role of this
gene in dermatitis is not fully understood. As C57BL mice
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Figure 4. Histological (a, b, c, d, e, and f) and immunological (g and h)
features of back skin tissue samples. Paraffin and frozen sections were
prepared from back skin samples obtained from 30-week-old transgenic and
DS mice maintained under SPF conditions. H&E staining (a and b) reveals
hyperkeratosis and thickening of the back skin in the transgenic mice, but not
in DS mice. Higher magnification images (c and d) of keratinocytes in (a) and
(b) reveal acanthosis and infiltration of inflammatory cells in the transgenic
mice, but not in DS mice. Blue-framed rectangles indicate the area of
vascularization with large numbers of inflammatory cells. Acidic toluidine
blue staining (e and f) of the back skin reveals a higher number of mast cells in
the transgenic mice than in DS mice. Red arrows and framed rectangles
indicate mast cells or areas with high numbers of mast cells. Frozen sections
from the transgenic mice were immunostained for mouse CD4 and red arrows
indicate the CD4-bearing T cells (g and h). Bar¼ 100mm.
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were commonly recognized as mice with a Th1 response
which are resistant to allergen stimulation, C57BL-Nh mice
were constructed and used to investigate the penetrance of
the TRPV3Gly573Ser gene for dermatitis. Although C57BL-Nh
mice did not develop dermatitis by 30 weeks of age, their
scratching behavior was significantly increased at 15 weeks
of age, compared with age-matched C57BL mice, and this
tendency continued for 15 weeks (Figures 6a–d and f).
Interestingly, the TRPV3Gly573Ser gene also caused a thicken-
ing of keratinocytes, an increased number of skin mast cells
and extension of the nerves to epidermal keratinocytes in
C57BL-Nh mice, compared with C57BL mice (Figure 6e).
DISCUSSION
Although TRPV3 with the Gly573Ser mutation exhibits
increased ion-channel activity in vitro (Xiao et al., 2008b)
and induces increased numbers of mast cells in vivo
(Asakawa et al., 2006), we needed to confirm whether the
increased activation of TRPV3 caused by this mutation was
similar to that caused by heat stimulation of wild-type TRPV3.
Histochemical analyses were carried out using skin samples
from DS and DS-Nh mice at 1, 3, and 7 days of age to
investigate this aspect, because the epidermal skin tempera-
ture changes dramatically from 37 1C at birth to less than
30 1C just after birth. We hypothesized that the lower
temperature (30 1C) would be sufficient to activate
TRPV3Gly573Ser (Xiao et al., 2008b), but not wild-type TRPV3
(Peier et al., 2002; Moqrich et al., 2005). Interestingly, we
found that the numbers of mast cells were similar in DS and
DS-Nh mice just after birth and only decreased significantly
in DS mice after several postnatal days (Figure S1). These
results indicate that wild-type TRPV3 activated by heat
stimulation maintains a larger number of mast cells.
In order to control both the quality and quantity of TRPV3
expression in transgenic mice, we used the putative promoter
sequence in the 50 region of TRPV3. Although the transgene
was detected in genomic DNA from all the transgenic lines,
mRNA encoding mutated TRPV3 was only recognized in the
Tg-2 line, and represented about 50% of the total TRPV3
expression in these mice. In the Tg-2 mice, we detected
higher levels of TRPV3 expression in the skin and testis,
consistent with a previous report (Xu et al., 2002). Although
we were unable to obtain further information regarding a role
for TRPV3 in the testis, male Tg-2 mice were infertile (data
not shown), whereas female Tg-2 mice showed normal
fertility. Interestingly, a temperature of 2–4 1C below body
temperature is essential for normal testicular function
(Thonneau et al., 1998) and higher temperatures in the testis
cause infertility (Wright et al., 1997). Taken together, TRPV3
may be important in the development of male infertility
caused by elevated testicular temperature.
We previously reported, using positional cloning methods,
that the Nh mutation caused hairlessness. Furthermore, we
speculated that the Gly573Ser mutation in TRPV3 may be a
cause of dermatitis, because our breeding study revealed that
the hairless and dermatitis phenotypes could not be
segregated from one another (Asakawa et al., 2006). This
study confirmed that TRPV3 is a key factor in the develop-
ment of AD in rodents, because TRPV3Gly573Ser transgenic
mice developed AD-like dermatitis when maintained under
SPF conditions, whereas DS mice did not. Our previous study
indicated that DS-Nh mice, which also possess TRPV3 with
the Gly573Ser mutation, do not develop AD-like dermatitis
under SPF conditions and that superantigen-producing S.
aureus is essential for the development of dermatitis
(Yoshioka et al., 2003). Although there is some discrepancy
regarding the development of dermatitis in these transgenic
and DS-Nh mice kept under SPF conditions, this may be
partially due to the levels of TRPV3 expression in the mice.
The total levels of TRPV3 expression (both endogenous and
exogenous) were higher in the transgenic mice than in
DS and DS-Nh mice (data not shown). C57BL-Nh mice were
also investigated to determine the penetrance of the
TRPV3Gly573Ser gene for dermatitis. Our data indicate that
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Figure 5. Impact of the Gly573Ser substitution in TRPV3 on scratching
behavior. (a) NGF responses in epidermal sheets from DS and DS-Nh mice
subjected to heat stimulation. Epidermal sheets were cultured in DMEM at 33
or 37 1C for 24 hours. Tissue-free supernatants were collected and their NGF
concentrations were measured by ELISA. Each value represents the
mean±SD of five mice. (b) Skin samples collected from transgenic and DS
mice were homogenized, and the NGF levels in their supernatants were
measured by ELISA. Each value represents the mean±SD of 5–7 mice. (c)
Immunohistochemical features of back skin tissue samples. Frozen sections
prepared from back skin samples obtained from 30-week-old transgenic and
DS mice maintained under SPF conditions were immunostained for mouse
NGF and PGP9.5. These arrows indicate NGF- or PGP9.5-expressing cells.
Bar¼100 mm. (d) The cumulative rubbing/scratching times of DS and
transgenic mice at 30 weeks of age were counted in 10 minutes observation
periods. Scratching behavior was significantly higher in transgenic mice than
in DS mice. Each value represents the mean±SD of 7–10 mice.
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gain-of function TRPV3 is essential but inadequate for the
development AD in certain mouse strains.
Serum levels of CCL11, CCL17, IL-13, IL-17, and MCP-1
were significantly higher in the TRPV3Gly573Ser transgenic
mice with dermatitis at 30 weeks of age than in age-matched
DS mice. Recently, higher levels of IL-13 were detected in a
certain population of patients with AD (Kaminishi et al.,
2002) and in DS-Nh mice with AD-like dermatitis (Yoshioka
et al., 2007), and IL-13 is thought to be a key cytokine in the
development of allergic diseases, such as AD (Purwar et al.,
2006). Typically, effector CD4 T cells are divided into two
distinct lineages on the basis of their cytokine production
profiles. However, recent studies have suggested the ex-
istence of a new lineage of Th17 cells, characterized by their
expression of IL-17, which is thought to be crucial for disease
pathogenesis in at least some forms of inflammatory diseases
(Harrington et al., 2006). Furthermore, tissue levels of IL-17
are significantly increased in skin lesions in the acute phase
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Figure 6. Analysis of C57BL-Nh mice. (a–d) Clinical features of C57BL-Nh mice. These mice maintained under conventional conditions for 30 weeks did not
develop dermatitis. (f) The cumulative rubbing/scratching times of C57BL and C57BL-Nh mice at 15 and 30 weeks of age were counted in 10 minutes
observation periods. Scratching behavior was significantly higher in C57BL-Nh mice than in C57BL mice. Each value represents the mean±SD of 7–10 mice.
Statistical significance was determined by Student’s t-test for unpaired two-group comparisons. (e) Histological and immunohistochemical features of back skin
tissue samples. Paraffin and frozen sections were prepared from back skin samples obtained from 15-week-old C57BL-Nh and C57BL mice maintained under
conventional conditions. Hematoxylin and eosin staining reveals the thickening of the keratinocytes in the C57BL-Nh mice, but not in C57BL mice. Acidic
toluidine blue staining of the back skin reveals a higher number of mast cells in the C57BL-Nh mice than in C57BL mice. Frozen sections from the transgenic
mice were immunostained for mouse PGP9.5. These arrows indicate mast cells or PGP9.5-expressing cells. Bar¼ 100mm.
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of AD compared with those in the chronic phase, and these
higher levels of IL-17 may contribute to tissue remodeling in
the skin of patients with acute AD (Toda et al., 2003).
Previous studies also found that the serum levels of CCL11
(Kaburagi et al., 2001), CCL17 (Fujisawa et al., 2002), and
MCP-1 (Kaburagi et al., 2001) were significantly increased in
patients with AD compared with normal control subjects.
TRPV3 is expressed in B and T lymphocytes isolated from the
spleen (Inada et al., 2006), however, it remains unclear
whether TRPV3 is functional in these lymphocytes and
whether or not it has an immune-related function. Taking
all these observations together, the transgenic mice with
dermatitis appear to be similar to patients with human AD
regarding their serological conditions, and TRPV3 may
contribute directly or indirectly to the development of these
conditions.
Although there are some questions regarding the use of
scratching behavior in mice as an indicator of pruritus, we
believe that it is a useful tool for its evaluation: scratching in
DS-Nh mice treated with the antipruritic agents, loratadine
(Yoshioka et al., 2006) and Eurax Cream (Novartis, Basel,
Switzerland; data not shown) was less than in untreated mice.
Interestingly, Ueda et al. (2006), reported that the scratching
behavior and skin lesions in hairless mice may be similar to
the chronic itching observed in AD. Furthermore, Kuraishi
et al. (1995), indicated that scratching behavior caused by
compound 48/80 and substance P injection was due to
itching, not pain, and such scratching behavior may be a
useful index for physiological and pharmacological studies of
antipruritic agents. We conclude that scratching behavior in
our mice was a good tool for investigating itching. Pruritus
with scratching is a typical symptom of AD (Kimura and
Miyazawa, 1989; Wahlgren 1999), and the reduction of
pruritus and scratching has come to be recognized as the
best approach for preventing the aggravation of skin lesions
and improving the quality of life of patients with AD
(Koblenzer, 1999). Interestingly, TRPV3 in keratinocytes is
activated at physiologic temperatures (431 1C; Xu et al.,
2002), inflammatory mediators (Hu et al., 2006), and
nitric oxide (Yoshida et al., 2006) in skin lesions. Considering
these facts, we hypothesize that TRPV3, which is activated
under the conditions of inflammatory dermatitis, is
directly associated with pruritus in AD patients, via NGF
production. To verify our hypothesis regarding the role and
involvement of TRPV3, we constructed C57BL-Nh mice.
Although C57BL-Nh mice did not develop dermatitis, we
found that scratching behavior was significantly increased in
these mice compared with age-matched C57BL mice, and we
therefore conclude that TRPV3 is important in the develop-
ment of pruritus.
Recently, it has become clear that sensitization caused by
repeated stimulation, which is known to be one of the unique
features of TRPV3, is controlled by Ca2þ (Xiao et al., 2008a).
Although the mechanism of TRPV3 sensitization is becoming
clear, its pathophysiological importance has not yet been
determined. Further work is required to establish the
association between TRPV3 and certain physiological con-
ditions. However, we have been able to report for the first
time, in this study, that epidermal TRPV3 has an impact on
dermatitis and is associated with the development of pruritus.
We therefore believe that TRPV3 is a potential therapeutic
target in human AD, via the management of inflammation
and pruritus.
MATERIALS AND METHODS
Identification of promoter region of TRPV3
To identify TRPV3 genomic sequences containing promoter activity,
different lengths of the 50-flanking region of TRPV3 were identified
by sequencing and inserted upstream of the firefly luciferase reporter
gene in pGL3-basic. pGL3-basic vectors, with and without a virus-
derived promoter sequence, were used as controls for the luciferase
activity. The plasmid DNA was purified using a Qiagen Midi-prep kit
(Qiagen Inc., Valencia, CA), transfected to XB-2 (ATCC, Manassas,
VA) by Lipofectamine2000 (Invitrogen, Carlsbad, CA), and cells
were harvested after 48 hours to measure luciferase activity.
Animals
A full-length cDNA encoding TRPV3Gly573Ser with its putative native
promoter sequence (Figure 1) was subcloned into a pSG5 vector.
TRPV3Gly573Ser transgenic mice were constructed using fertilized
eggs from BDF1 mice according to a common procedure, and then
inbred with DS mice for 7–10 generations. DS-Nh mice were crossed
with C57BL/6 mice (N1 generation). F1 progenies with the
hairlessness mutation were backcrossed with C57BL/6 mice for
several generations to produce C57BL/6-Nh mice. All mice used in
this study were maintained in cages, exposed to a 12 hours
light/12 hours dark cycle and provided with standard food
and water ad libitum. The animals were housed in rooms under
SPF or conventional conditions. This study was conducted
according to the Guidelines for Animal Experimentation at Shionogi
and Co. Ltd.
Gene analysis
Genomic DNA was prepared from the tail of each mouse, and 7–8 mg
of the DNA was digested with Puv II. Next, the digested DNA was
electrophoresed in a 1.0% agarose gel and transferred to a Hybond-
Nþ nylon membrane (GE Healthcare Bio-Sciences AB, Uppsala,
Sweden). A DNA fragment (477 bp) of TRPV3 was prepared by PCR
using biotin-labeled primers and used as a probe to detect
endogenous and exogenous TRPV3.
Total RNA was isolated from mice using TRIzol Reagent
(Invitrogen) followed by cleaning up using RNeasy columns
(Qiagen). Real-time quantitative RT-PCR was used to verify the
variations of gene expression of TRPV3. Primers and SYBR Premix Ex
Taq for real-time quantitative RT-PCR reactions were purchased
from Takara Bio (Siga, Japan), and expression levels of gene were
assayed following the manufacturer’s protocol. Data were normal-
ized against the relative expression of glyceraldehyde-3-phosphate
dehydrogenase.
Measurement of serum IgE and cytokine levels
Pooled sera collected from 30-week-old DS and transgenic mice
maintained under SPF conditions were stored at 80 1C until
analysis. Total serum IgE levels were measured using a sandwich
ELISA kit (Yamasa Shoyu Co. Ltd., Chiba, Japan). Serum CCL11, IL-
13, IL-17, IFN-g, and MCP-1 levels were measured using Bio-Plex
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(Bio-Rad Laboratories, Hercules, CA). Serum thymus and activation-
regulated chemokine (CCL17) levels were measured using an ELISA
kit (R&D Systems, Minneapolis, MN). Each experiment was carried
out 3–4 times and the mean results were used to determine the
significance of differences in the levels.
Histopathological and immunohistochemical analyses
Paraffin sections were prepared from skin samples obtained
from transgenic, DS and DS-Nh mice at appropriate days or
weeks of age. The sections were stained with hematoxylin and
eosin and/or acidic toluidine blue for histopathological analysis by
light microscopy. Paraffin sections were also prepared for immuno-
histochemical analyses. These sections were pretreated with
2.5 mg ml1 of purified mouse IgG (BD Pharmingen, San Diego,
CA) in phosphate-buffered saline (PBS) containing 1% bovine serum
albumin and Dako Protein Block (Dako, Glostrup, Denmark). Next,
the sections were immunostained with a rabbit anti-mouse PGP9.5
(Millipore, Billerica, MA). After washing in PBS, the sections were
treated with biotin-conjugated secondary antibodies (BD Pharmin-
gen). After washing with PBS, the sections were treated with
UltraAvidin-Horseradish Peroxidase (Leinco Technology Inc., St.
Louis, MO). Finally, antibody-positive cells in the sections were
visualized by enzyme-based color staining after washing with PBS.
Frozen sections were also prepared and pretreated with
2.5 mg ml1 of purified mouse IgG (BD Pharmingen) in PBS
containing 1% bovine serum albumin and Dako Protein Block
(Dako Corporation). Next, the sections were immunostained with a
rat anti-mouse CD4 antibody (clone H129.19; BD Pharmingen), a
rabbit anti-mouse NGF antibody (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA), or rabbit anti-mouse TRPV3 polyclonal antibodies
generated by immunization of rabbits with polypeptides VRL3-1
(RTTAPGGNPVVLTEKC) and VRL3-2 (NPVVLTECRPADLTPC) shar-
ing the same sequences as mouse TRPV3. After washing in PBS, the
sections were treated with biotin-conjugated secondary antibodies
(Pharmingen). After washing with PBS, the sections were treated with
UltraAvidin-Horseradish Peroxidase (Leinco Technologies Inc.).
Finally, antibody-positive cells in the sections were visualized by
enzyme-based color staining after washing with PBS.
Measurement of NGF in skin tissues from mice and NGF
responses in epidermal sheets subjected to heat stimulation
Ear tissue was collected from TRPV3Gly573Ser transgenic and DS mice
at 6–8 weeks of age using an 8-mm biopsy punch (Kai Industries Co.
Ltd., Gifu, Japan), sterilized with Isodine (Meiji Seika Kaisha Ltd.,
Tokyo, Japan) and washed with PBS. Pairs of epidermal sheets were
obtained from each ear using two pairs of tweezers, placed in 24-
well microplates (Corning Costar Co., Corning, NY) and incubated in
Dulbecco’s modified Eagle’s medium containing 10% fetal calf
serum, 100 U ml1 of penicillin, and 100 mg ml1 streptomycin at 33
or 37 1C for 24 hours. Tissue-free supernatants were collected, and
their NGF levels were measured using an ELISA kit (Millipore),
according to the manufacturer’s instructions.
Skin tissue samples were collected from DS and TRPV3Gly573Ser
transgenic mice, homogenized in M-PER Mammalian Protein
Extraction Reagent (Pierce, Rockford, IL) and stored at 80 1C until
analysis. After the homogenates had been thawed and centrifuged,
the supernatants were collected and their NGF levels were measured
using an ELISA kit as described above.
Spontaneous scratching behavior
Itching was evaluated in 15- and 30-week-old C57BL/6 and C57BL/
6-Nh mice and in 30-week-old DS and TRPV3Gly573Ser transgenic
mice by measuring the cumulative rubbing/scratching times during
10 minutes observation periods.
Statistical analysis
Statistical analyses were carried out using Student’s t-test for
unpaired comparisons, unless otherwise stated.
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SUPPLEMENTARY MATERIAL
Figure S1. Influence of the Gly573Ser substitution in TRPV3 on the increase in
the number of mast cells.
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